Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

There are currently six drugs approved by the FDA to treat overweight and obesity: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide and tirzepatide -- the latter ...

Learn how to get a CPAP machine for sleep apnea, including how to get a prescription, the cost of a CPAP machine and what to ...

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard ... obesity therapy Zepbound (tirzepatide), which helped ...